Amphastar Pharmaceuticals Inc’s recently made public that its Director Petersen Floyd F. unloaded Company’s shares for reported $21714.0 on Apr 01 ’24. In the deal valued at $43.43 per share,500 shares were sold. As a result of this transaction, Petersen Floyd F. now holds 79,333 shares worth roughly $3.24 million.
Then, PETERS WILLIAM J sold 18,136 shares, generating $842,883 in total proceeds. Upon selling the shares at $46.48, the CFO, EVP & TREASURER now owns 111,490 shares.
Before that, ZASLOFF MICHAEL A sold 12,500 shares. Amphastar Pharmaceuticals Inc shares valued at $589,724 were divested by the Director at a price of $47.18 per share. As a result of the transaction, ZASLOFF MICHAEL A now holds 21,326 shares, worth roughly $0.87 million.
JP Morgan initiated its Amphastar Pharmaceuticals Inc [AMPH] rating to an Overweight in a research note published on March 05, 2024; the price target was $60. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in mid November with a ‘”a Neutral”‘ rating.
Price Performance Review of AMPH
On Tuesday, Amphastar Pharmaceuticals Inc [NASDAQ:AMPH] saw its stock jump 0.29% to $40.90. Amphastar Pharmaceuticals Inc shares have fallen nearly -33.87% since the year began. Nevertheless, the stocks have fallen -2.97% over the past one year. While a 52-week high of $67.66 was reached on 01/05/24, a 52-week low of $35.62 was recorded on 04/12/24. SMA at 50 days reached $46.99, while 200 days put it at $52.24. A total of 0.31 million shares were traded, compared to the trading of 0.4 million shares in the previous session.
Levels Of Support And Resistance For AMPH Stock
The 24-hour chart illustrates a support level at 40.40, which if violated will result in even more drops to 39.89. On the upside, there is a resistance level at 41.42. A further resistance level may holdings at 41.93. The Relative Strength Index (RSI) on the 14-day chart is 35.74, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.13, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.84%. Stochastics %K at 25.23% indicates the stock is a holding.
The most recent change occurred on July 29, 2022 when CapitalOne began covering the stock and recommended ‘”an Overweight”‘ rating along with a $44 price target.
